International Workshop on Aging & HIV 2021

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

• Dorcas Baker, RN, BSN, ACRN, MA, Johns Hopkins University School of Nursing, MidAtlantic AIDS Education and Training Center (AETC), United States
• Bruce Brew, MD, St Vincent's Hospital, Australia
• Marie-Josée Brouillette, MD, McGill University Health Centre, Canada
• Simon Collins, HIV i-Base, United Kingdom
• Daniel Duprez, MD, University of Minnesota (Cardiology), United States
• Meredith Greene, MD, UCSF, United States
• Giovanni Guaraldi, MD, Policlinico Modena, Italy
• Marcia McDonnell Holstad, PhD, Emory University, United States
• Jordan Lake, MD, MSc, UTHealth, United States
• Alan Landay, PhD, Rush University Medical Center, United States
• Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
• Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona , Spain
• Kelly O'Brien, PhD, BScPT, BSc, University of Toronto, Department of Physical Therapy, Canada
• Brendan Payne, PhD, Newcastle University, United Kingdom
• Molly Perkins, PhD, Emory University School of Medicine, United States
• Matilde Sanchez Conde, MD, PhD, Hospital Ramón y Cajal, Spain
• Eugenia Siegler, MD, Weill Cornell Medicine, United States
• Jeff Taylor, HIV + Aging Research Project - Palm Springs, United States
• Phyllis Tien, MD, MSc, University of California, San Francisco, United States
• Cara Wilson, MD, University of Colorado, United States

Industry LIaison Board

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

• Andrew Clark, MD, ViiV Healthcare, United Kingdom
• Richard Haubrich, MD, Gilead Sciences, United States
• Christian Marsolais, PhD, Theratechnologies, Canada